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The synthesis and secretion of gonadotropins is the final result of the interactions between central and peripheral signals. Hypothalamic GnRH stimulates the synthesis and secretion of FSH and LH (1) . Testis inhibits gonadotropin secretion, as revealed by FSH and LH increase after orchidectomy (2) (3) (4) . Testicular factors involved in the regulation of gonadotropin secretion include androgens and peptides (inhibins, activins and follistatin) (5, 6) . These factors target their actions to hypothalamus and pituitary in controlling FSH and LH secretion (6, 7) .
In order to discriminate between the site of action of testicular factors, two different experimental approaches have been used: analysis of in vitro gonadotropin secretion by pituitaries challenged by androgens and/or peptides (7) (8) (9) (10) (11) ; and in vivo models with impaired GnRH actions by administration of potent GnRH antagonists (12) (13) (14) (15) (16) (17) (18) or hypothalamic deafferentation (19) . In addition, the existence of specific antiandrogens, such as flutamide (20) or selective toxins, against Leydig cells, such as ethylene dimethane sulphonate (EDS) (21, 22) , has allowed the effects of androgens and peptides in the control of gonadotropin secretion to be differentiated (23) .
Testicular androgens acting at the hypothalamic level decrease FSH and LH secretion (1) . However (12) (13) (14) (15) (16) (17) (18) . These direct actions of androgens at the pituitary level were not observed for LH (12) (13) (14) . Inhibins and activins control FSH secretion, acting mainly at the pituitary level (27, 28) . Although the lack of action of testicular peptides on LH secretion has been reported, GnRH-induced LH secre¬ tion can be modulated by inhibin (7, 29) .
We have proposed recently that non-Leydig cell non-androgenic testicular factor(s) modulates LH and FSH secretion (23 (33) . Also, a reduction of ß-LH mRNA after administration of GnRH antagonist (17) or GnRH agonist-induced desensitization (34) (27, 28) , although central actions of inhibins also have been reported (36) and cannot be ruled out by this experimental approach. Because the existence of a specific FSH-releasing factor has been suggested repeatedly (37, 38) 
